The N-able trademarks, service marks, and logos are the exclusive property of N-able Solutions ... "Darren is a proven, growth-oriented leader... Baxter International Inc. , a global medtech leader, ...

Baxter International Inc. closed 24.01% short of its 52-week high of $44.01, which the company reached on March 8th.

Baxter International shares surged Thursday after the medical device maker's fourth-quarter results topped estimates.

Barclays reinstated coverage of Baxter (BAX) with an Overweight rating and $39 price target The firm updated its sales projections to reflect ...

Reports Q4 revenue $2.75B, consensus $2.67B. “Our 2024 performance and related strategic milestones reflect Baxter’s (BAX) growing momentum in ...

Baxter International Inc. ( NYSE: BAX) Q4 2024 Earnings Conference Call February 20, 2025 8:30 AM ET Clare Trachtman - SVP and Chief IRO Brent Shafer - Chairman, and Interim CEO Heather Knight - COO ...

The stock's fall snapped a three-day winning streak.

Q4 2024 Management View Interim CEO Brent Shafer highlighted the completion of the Vantive sale as a significant milestone in Baxter's transformation strategy and noted the company's focus on ...

Baxter International Inc. (NYSE:BAX – Get Free Report) has been assigned an average recommendation of “Hold” from the ten brokerages that are covering the stock, MarketBeat.com reports.

DEERFIELD, Ill., February 11, 2025--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash ...

Regarding the company’s financial performance, Baxter International Inc. announced that its results for the fourth quarter and full year ended December 31, 2024, are expected to be in line with ...

DEERFIELD, Ill., February 13, 2025--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Citi - 2025 Medtech & Life Sciences Access Day on Thursday ...